As shown in Fig. 5F, bioinformatics analysis indicated that, in lung cancer (n = 107) and breast cancer (n = 112) tissues, the mRNA levels of Prame were higher than that of the adjacent tissues. This evidence concerns the gene PRAME and lung carcinoma.